269 related articles for article (PubMed ID: 37079973)
21. Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.
Vila-Castelar C; Guzmán-Vélez E; Pardilla-Delgado E; Buckley RF; Bocanegra Y; Baena A; Fox-Fuller JT; Tirado V; Muñoz C; Giraldo M; Acosta-Baena N; Rios-Romenets S; Langbaum JB; Tariot PN; Lopera F; Reiman EM; Quiroz YT
J Alzheimers Dis; 2020; 77(4):1743-1753. PubMed ID: 32925067
[TBL] [Abstract][Full Text] [Related]
22. Naming in dementia secondary to Parkinson's, Huntington's, and Alzheimer's diseases.
Frank EM; McDade HL; Scott WK
J Commun Disord; 1996; 29(3):183-97. PubMed ID: 8799853
[TBL] [Abstract][Full Text] [Related]
23. Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS.
Beatty WW; Ryder KA; Gontkovsky ST; Scott JG; McSwan KL; Bharucha KJ
Arch Clin Neuropsychol; 2003 Jul; 18(5):509-20. PubMed ID: 14591446
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
25. Spoken language production in Huntington's and Parkinson's diseases.
Murray LL
J Speech Lang Hear Res; 2000 Dec; 43(6):1350-66. PubMed ID: 11193957
[TBL] [Abstract][Full Text] [Related]
26. Ideomotor limb apraxia in Huntington's disease: a case-control study.
Hödl AK; Hödl E; Otti DV; Herranhof B; Ille R; Bonelli RM
J Neurol; 2008 Mar; 255(3):331-9. PubMed ID: 18305889
[TBL] [Abstract][Full Text] [Related]
27. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
28. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal changes in cognition in Parkinson's disease with and without dementia.
Johnson DK; Galvin JE
Dement Geriatr Cogn Disord; 2011; 31(2):98-108. PubMed ID: 21242691
[TBL] [Abstract][Full Text] [Related]
30. Preclinical cognitive trajectories differ for Alzheimer's disease and vascular dementia.
Laukka EJ; Macdonald SW; Fratiglioni L; Bäckman L
J Int Neuropsychol Soc; 2012 Mar; 18(2):191-9. PubMed ID: 22264384
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological Management of Apathy in Dementia.
Azhar L; Kusumo RW; Marotta G; Lanctôt KL; Herrmann N
CNS Drugs; 2022 Feb; 36(2):143-165. PubMed ID: 35006557
[TBL] [Abstract][Full Text] [Related]
32. [Comparative study on the clinical features of Alzheimer's disease and vascular dementia].
Chen X; Zhang ZX; Huang JB; Wen HB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):122-7. PubMed ID: 15171546
[TBL] [Abstract][Full Text] [Related]
33. Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease.
Fritz NE; Kegelmeyer DA; Kloos AD; Linder S; Park A; Kataki M; Adeli A; Agrawal P; Scharre DW; Kostyk SK
Gait Posture; 2016 Oct; 50():1-7. PubMed ID: 27544062
[TBL] [Abstract][Full Text] [Related]
34. Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease.
Martinez-Horta S; Horta-Barba A; Perez-Perez J; Sampedro F; de Lucia N; De Michele G; Kehrer S; Priller J; Migliore S; Squitieri F; Castaldo A; Mariotti C; Mañanes V; Lopez-Sendon JL; Rodriguez N; Martinez-Descals A; Garcia-Ruiz P; Júlio F; Januário C; Delussi M; de Tommaso M; Noguera S; Ruiz-Idiago J; Sitek EJ; Nuzzi A; Pagonabarraga J; Kulisevsky J;
J Neurol; 2020 May; 267(5):1527-1535. PubMed ID: 32030521
[TBL] [Abstract][Full Text] [Related]
35. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C
Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091
[TBL] [Abstract][Full Text] [Related]
36. Postural deficits in Huntington's disease when performing motor skills involved in daily living.
Panzera R; Salomonczyk D; Pirogovosky E; Simmons R; Goldstein J; Corey-Bloom J; Gilbert PE
Gait Posture; 2011 Mar; 33(3):457-61. PubMed ID: 21256027
[TBL] [Abstract][Full Text] [Related]
37. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
38. Differential spatial distribution of white matter lesions in Parkinson's and Alzheimer's diseases and cognitive sequelae.
Grey MT; Mitterová K; Gajdoš M; Uher R; Klobušiaková P; Rektorová I; Rektor I
J Neural Transm (Vienna); 2022 Aug; 129(8):1023-1030. PubMed ID: 35819634
[TBL] [Abstract][Full Text] [Related]
39. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
Front Immunol; 2022; 13():997240. PubMed ID: 36263032
[TBL] [Abstract][Full Text] [Related]
40. Neuropsychological performance in Alzheimer's disease and vascular dementia: comparisons in a memory clinic population.
Baillon S; Muhommad S; Marudkar M; Suribhatla S; Dennis M; Spreadbury C; Munro D; Lindesay J
Int J Geriatr Psychiatry; 2003 Jul; 18(7):602-8. PubMed ID: 12833304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
